Related Experiment Video
Updated: Jun 13, 2026

05:33
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
Towards robust foundation models for digital pathology
Jonah Kömen1,2, Edwin D de Jong3, Julius Hense1,2
1Berlin Institute for the Foundations of Learning and Data (BIFOLD), Berlin, Germany.
Nature Communications
|June 11, 2026
Summary
Biomedical Foundation Models (FMs) show robustness deficits to non-biological features, risking clinical AI adoption. PathoROB benchmark reveals these issues, highlighting the need for robust FMs in healthcare.
Area of Science:
- Biomedical AI
- Computational Pathology
- Machine Learning in Healthcare
Background:
- Biomedical Foundation Models (FMs) are increasingly used in healthcare research and clinical validation.
- These models may learn non-biological features (e.g., lab procedures, scanner variations), posing risks for reliable clinical deployment.
Purpose of the Study:
- To introduce PathoROB, a public benchmark for quantifying the robustness of FMs to non-biological features in pathology.
- To assess both representation-level and output-level robustness of FMs in clinically relevant tasks.
Main Methods:
- Developed PathoROB benchmark for evaluating FM robustness against non-biological variations.
- Assessed representation-level robustness using a robustness index.
- Evaluated output-level robustness across patch/slide prediction, case retrieval, and clustering tasks for 20 FMs.
Main Results:
- All 20 evaluated FMs exhibited robustness deficits to non-biological features.
- Significant performance differences were observed among the evaluated FMs.
- Non-robust FM representations were found to cause major downstream diagnostic errors.
Conclusions:
- Robustness evaluation is critical for validating pathology FMs before clinical deployment.
- While robust FMs, vision-language alignment, and post-hoc methods can mitigate risks, they do not eliminate them entirely.
- PathoROB provides a framework for assessing and enhancing FM robustness in biomedical applications.
